---
$id: https://graph.org.ai/products/commodity/51142531
$type: Product
source: UNSPSC
code: "51142531"
title: "Mazaticol"
class: "51142500"
classTitle: "Antiparkinson drugs"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Mazaticol

**UNSPSC Code**: 51142531
**Class**: [Antiparkinson drugs](Antiparkinson drugs.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anticholinergic agent with the molecular formula C20H25NO3S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier I6X824OGWZ, chemically known as 6,6,9-trimethyl-9-azabicyclo(3.3.1)non-3beta-yl di-2-thienylglycolate but generally known as mazaticol, which bears US NIH Compound Identifier 68667. European Medicines Agency schedules Mazaticol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08655MIG. The term MAZATICOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 27, No. 10 1973, List 13). World Health Organization schedules mazaticol in its Anatomical Therapeutic Chemical (ATC) Classification. MAZATICOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule mazaticol under HS 29349990 and SITC 51579. As of Q4 2014, MAZATICOL remains the US FDA Preferred Term for this commodity. Mazaticol bears US NLM identifiers UMLS ID C0065760 and NCI Concept Code C82233. SMILES: S1C(C(O)(C(=O)OC2CC3N(C(CCC3(C)C)C2)C)C2SCCC2)CCC1.

